🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to determine which treatment will be...
Status
Unknown
Location
Department of Cardiology, Nagoya University Graduate School of Medicine
Start Date
2013-04
Trial ID
NCT01893788
Treatments Being Tested
This study is a randomized, placebo-controlled, double-blind, multi-center ...
Status
Completed
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT02345044
Treatments Being Tested
To evaluate the changes in serum aldosterone and plasma renin activity on D...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-10
Trial ID
NCT00990223
Treatments Being Tested
The goal of this clinical trial is to determine if the medication eplerenon...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2026-03-20
Trial ID
NCT07238400
Treatments Being Tested
This study compares Spironolactone, a non-selective aldosterone antagonist,...
Status
Withdrawn
Location
University Hospital of Skane
Start Date
2013-02
Trial ID
NCT01801228
Treatments Being Tested
This is a Phase I, open-label, randomized, parallel trial to evaluate the p...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-05
Trial ID
NCT02607657
The purpose this study is to compare the efficacy of eplereonone and losart...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2003-04
Trial ID
NCT00649311
Treatments Being Tested
The purpose of this study is to investigate the safety and tolerability of ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2010-10
Trial ID
NCT01237899
Treatments Being Tested